WS #17036

The macro landscape has shifted decisively toward a hawkish repricing following the release of the October employment report, which showed 165,000 nonfarm payrolls—more than double consensus—and a revision of prior months that pushed the unemployment rate down to 4.1%. This robust labor data has solidified market expectations for a December rate hike, creating a headwind for high-multiple growth stocks despite a midday rebound in chipmakers. The labor strength also contributed to a sharp drop in gold ($4,072) and Brent crude ($97.49), as higher-for-longer rates and a stronger dollar dampened commodity demand. In the technology sector, the narrative remains bifurcated. While Intel continues to suffer from deep-seated AI execution doubts, TSMC is maintaining strong buy ratings based on superior free cash flow growth, highlighting a divergence in semiconductor fortunes. Meanwhile, biotech saw a bright spot with Moderna beating Q3 estimates and raising guidance. Geopolitically, tensions are escalating as Iran threatens missile strikes on European bases, adding a risk premium to energy and defense sectors, though the immediate market reaction has been muted by the dominant macro focus on the Fed.